The problem concerns a supplied component in the device used to deliver the fentanyl spray which may result in patients receiving a sub-optimal dose of medication. A detailed investigation is underway but, as a precautionary measure to ensure patient safety, a temporary halt to the study has been implemented and all affected clinical trial supplies will be recalled.